Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Nephros Inc. (NEPH)

Bionano Genomics, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $38.1M against $16.1M — 2.4× the size. Bionano Genomics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 23.4×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against 10.0%. Nephros Inc. has the higher net margin (8.38% vs −106.6%) and the higher return on invested capital (14.1% vs −81.7%). Across the 18 metrics below, Nephros Inc. leads on 14 and Bionano Genomics, Inc. on 4.

Valuation

Metric BNGO NEPH Medical Instruments & Supplies median
P/E n/m 23.43 33.75
P/S 0.48 1.91 2.52
P/B 0.46 3.31 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m 19.82 14.62
EV/Sales 0.72 1.69 2.88
Earnings yield (241.60%) 4.27% (2.67%)
Free cash flow yield (142.62%) (1.98%) 0.09%

Profitability

Metric BNGO NEPH Medical Instruments & Supplies median
Gross margin 47.51% 61.26% 54.29%
Operating margin (106.67%) 7.92% 1.07%
Net margin (106.58%) 8.38% (1.61%)
Free cash flow margin (67.87%) (3.19%) 1.08%
Return on equity (83.56%) 16.10% (1.32%)
Return on assets (52.04%) 12.39% 0.00%
Return on invested capital (81.68%) 14.11% 0.00%

Growth

Metric BNGO NEPH Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% 24.20% 8.85%
EPS growth (last fiscal year) 94.50% 1,471.43% 8.65%
Revenue growth, 5-year CAGR 27.37% 17.02% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO NEPH Medical Instruments & Supplies median
Debt to equity 0.11 0.00 0.10
Current ratio 2.48 4.07 2.48
Net debt to EBITDA 1.06 (4.20) 0.89

Dividend

Metric BNGO NEPH Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric BNGO NEPH Medical Instruments & Supplies median
Market cap 16.13m 38.12m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack